16856 results for "sec+and+unspecified+malignant+neoplasm"

in 22.14 milliseconds.

• Transcriptome of (monocytes and dendritic cells ), from donor S1, replicate 2 control

  Dataset EGAD00001009007

• Transcriptome of (monocytes and dendritic cells ), from donor S1, replicate 1 control

  Dataset EGAD00001009006

• Transcriptome of (monocytes and dendritic cells ), from donor S2, replicate 2 control

  Dataset EGAD00001009009

• Exome sequencing of nine PCC/PGL tumors

  Exome sequencing of nine PCC/PGL tumors, SF and FFPE samples

  Dataset EGAD00001001854

• RNAseq data

  RNAseq data for 10 patients: 10 tumors and 10 cell lines

  Dataset EGAD00001002691

• Genome-wide DNA Methylation Analysis Reveals a Unique Methylation Pattern for Pleural Mesothelioma Compared to Healthy Pleura and Other Lung Diseases

  Study EGAS00001007783

• Targeted Sequencing Xenturion

  Targeted sequencing of a biobank of PDOs PDXs and LMHs

  Dataset EGAD00001009653

• Biomarker Data Subset

  This dataset contains data for CBC counts and absolute protein abundance measurements from ELISA experiments.

  Dataset EGAD00001011163

• Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens

  Study EGAS00001007404

• Genomic Characterization of Metastatic Castration Resistant Prostate Cancer

  Biopsies of castration resistant prostate cancer metastases were subjected to whole genome sequencing (WGS), along with RNA-sequencing (RNA-Seq). The overarching goal of the study is to illuminate molecular mechanisms of acquired resistance to therapeutic agents, and particularly androgen signaling inhibitors, in the treatment of metastatic castration resistant prostate cancer (mCRPC).

  Study phs001648